Pages that link to "Q238512"
Jump to navigation
Jump to search
The following pages link to fluorouracil (Q238512):
Displayed 50 items.
- World Health Organization Model List of Essential Medicines (Q37155) (← links)
- FOLFOX (Q117636) (← links)
- breast cancer (Q128581) (← links)
- stomach cancer (Q189588) (← links)
- skin cancer (Q192102) (← links)
- pancreatic cancer (Q212961) (← links)
- acenocoumarol (Q304088) (← links)
- actinic keratosis (Q422225) (← links)
- meibomian cyst (Q769595) (← links)
- basal-cell carcinoma (Q809758) (← links)
- FOLFIRI (Q1389369) (← links)
- invasive ductal carcinoma (Q1671685) (← links)
- head and neck cancer (Q1783924) (← links)
- rectum cancer (Q2739660) (← links)
- keratosis (Q3667186) (← links)
- Cyclophosphamide Methotrexate Fluorouracil (Q5198945) (← links)
- IFL chemotherapy regimen (Q5970794) (← links)
- (Q12963975) (redirect page) (← links)
- FOLFIRINOX (Q17144959) (← links)
- head and neck squamous cell carcinoma (Q18348812) (← links)
- gastrointestinal carcinoma (Q18553565) (← links)
- rectum adenocarcinoma (Q18554959) (← links)
- colon cancer (Q18555025) (← links)
- colon adenocarcinoma (Q18555055) (← links)
- colonic benign neoplasm (Q18555061) (← links)
- gastric adenocarcinoma (Q18556047) (← links)
- pancreatic adenocarcinoma (Q18556189) (← links)
- anal carcinoma (Q18556540) (← links)
- anal squamous cell carcinoma (Q18556840) (← links)
- Silencing of keratinocyte growth factor receptor restores 5-fluorouracil and tamoxifen efficacy on responsive cancer cells (Q21092205) (← links)
- Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system (Q21146752) (← links)
- response to 5-fluorouracil (Q22274618) (← links)
- Eye abnormality in Drosophila melanogaster exposed to 5-fluorouracil during development (Q23911495) (← links)
- Sampling and mass spectrometric analytical methods for five antineoplastic drugs in the healthcare environment (Q23914149) (← links)
- Detection and measurement of surface contamination by multiple antineoplastic drugs using multiplex bead assay (Q23914798) (← links)
- Detection of 5-fluorouracil surface contamination in near real time (Q23914799) (← links)
- Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device (Q23919324) (← links)
- Pattern of response of intact drosophila to known teratogens (Q23919791) (← links)
- Development of an HPLC method for simultaneous analysis of five antineoplastic agents (Q23920413) (← links)
- A new monitoring method using solid sorbent media for evaluation of airborne cyclophosphamide and other antineoplastic agents (Q23920414) (← links)
- Biological monitoring screening of patients provided antineoplastic drugs including adriamycin, cyclophosphamide, 5-fluorouracil, methotrexate, and vincristine (Q23922568) (← links)
- Monitoring method for surface contamination caused by selected antineoplastic agents (Q23923245) (← links)
- Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery (Q24187923) (← links)
- 5-Fluorouracil for glaucoma surgery (Q24200343) (← links)
- Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery (Q24201611) (← links)
- Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery (Q24234216) (← links)
- Intraoperative 5-Fluorouracil for glaucoma surgery (Q24234716) (← links)
- Intraoperative 5-Fluorouracil for glaucoma surgery (Q24240539) (← links)
- Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery (Q24243450) (← links)
- Mitomycin C versus 5-Fluorouracil for wound healing in glaucoma surgery (Q24244471) (← links)